Endeavor BioMedicines IPO

endeavorbiomedicines.comHealthcare / BioTech & Pharma

Endeavor BioMedicines is a biotechnology company that is striving to discover new ways to treat patients who have life-threatening diseases. The company is working toward that goal by aiming to combat the drivers of fibrosis and oncology, which are both areas of medicine that have unmet needs. Endeavor BioMedicines was founded in 2018 by John Hood and Miguel de los Rios and is headquartered in San Diego, CA. In addition to looking for treatments that alleviate symptoms, Endeavor BioMedicines is seeking ways to reverse the effects of terminal illnesses.

Buy or sell Endeavor BioMedicines stock Learn more about Endeavor BioMedicines stock

Learn more about Endeavor BioMedicines

Is Endeavor BioMedicines a publicly traded company?

Endeavor BioMedicines is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Will Endeavor BioMedicines go IPO?

Endeavor BioMedicines has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

What is Endeavor BioMedicines's IPO price?

The IPO price for Endeavor BioMedicines will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.

Can you invest in Endeavor BioMedicines pre-IPO?

Endeavor BioMedicines is privately held company and is not publicly traded, therefor investing in Endeavor BioMedicines pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

What is the value of my Endeavor BioMedicines shares?

To determine the value of your Endeavor BioMedicines shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Endeavor BioMedicines shares. You can also learn more about how to sell your private shares before getting started.

Can you sell Endeavor BioMedicines before it goes public?

Yes, you can seek to sell shares in Endeavor BioMedicines while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

What is Endeavor BioMedicines's funding to date?

Endeavor BioMedicines has raised $295.58MM to date.

When was Endeavor BioMedicines founded?

Endeavor BioMedicines was founded in 2018.

Who are Endeavor BioMedicines's major investors?

Fidelity Management & Research

T. Rowe Price

Longitude Capital

Perceptive Advisors

Woodline Partners

The Invus Group

Ally Bridge Group

Avidity Partners

Piper Sandler

SymBiosis Capital Management

Revelation Partners

CE-Ventures

Omega Funds

Matrix Capital Management

Abrdn

Eckuity

Silver Arch Bio

Velosity Capital

Endeavor BioMedicines funding rounds and last known valuation

Date	Funding Round	Funding Raised	Price per Share	Last Known Valuation
4/24/2024	Series C	$132.58MM raised	$XXX.XX	$XXX.XX
2/7/2022	Series B	$101MM raised	$XXX.XX	$XXX.XX
1/7/2021	Series A-1, A-2 and A-3	$62MM raised	$XXX.XX	$XXX.XX

Based on primary financings

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.